17-O-[N-(3-CHLOROPROPYL)-CARBAMOYL]-LATRUNCULIN_A
Compound with spectra: 1 NMR
![17-O-[N-(3-CHLOROPROPYL)-CARBAMOYL]-LATRUNCULIN_A](/api/compound/Kn0c0Z1Zvhf.png?ph=true&h=300&w=458 "17-O-[N-(3-CHLOROPROPYL)-CARBAMOYL]-LATRUNCULIN_A")
| SpectraBase Compound ID | Kn0c0Z1Zvhf |
|---|---|
| InChI | InChI=1S/C26H37ClN2O6S/c1-18-8-5-3-4-6-9-19(2)14-23(30)33-21-15-20(11-10-18)34-26(16-21,22-17-36-25(32)29-22)35-24(31)28-13-7-12-27/h3-5,8,14,18,20-22H,6-7,9-13,15-17H2,1-2H3,(H,28,31)(H,29,32)/b4-3+,8-5-,19-14-/t18-,20-,21-,22-,26+/m0/s1 |
| InChIKey | ZBKZGKOPNVIOTD-FLFSSDHLSA-N |
| Mol Weight | 541.1 g/mol |
| Molecular Formula | C26H37ClN2O6S |
| Exact Mass | 540.206086 g/mol |
| Enantiomer InChIKey | ZBKZGKOPNVIOTD-LEGVJVDOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
17-O-[N-(2-CHLOROETHYL)-CARBAMOYL]-LATRUNCULIN_A
17-O-[N-(2-BROMOETHYL)-CARBAMOYL]-LATRUNCULIN_A
N-[6-(methylsulfonyl)-1,3-benzothiazol-2-yl]-2-phenyl-4-quinolinecarboxamide
1,2,4-Methenobenzo[b]cyclopropa[d]pyran, 5,6-dichloro-1,1a,2,3a,4,5,7a,7b-octahydro-, (1.alpha.,1a.beta.,2.alpha.,3a.beta.,4.alpha.,5.beta.,7a.beta.,7b.beta.,8S*)-
(.+-.)-2T,3T-Epoxy-5c,6T-dimethoxy-4c-phthalimido-cyclohexyl trichloroacetimidate
METHYL-2-alpha-MALONOYLOXY-9-EPI-ENT-7,15-PIMARADIENE
.beta.-D-Mannofuranosiduronic acid, methyl 5-(acetylamino)-5-deoxy-, methyl ester, 2,3-diacetate
.alpha.-D-Mannofuranosiduronic acid, methyl 5-(acetylamino)-5-deoxy-, methyl ester, 2,3-diacetate
.beta.-D-Allofuranosiduronic acid, methyl 5-(acetylamino)-5-deoxy-, methyl ester, 2,3-diacetate
7H-Furo[3,2-g][1]benzopyran-7-one, 9-[[4-[2-(acetyloxy)-1,1-dimethyl-3-[(7-oxo-7H-furo[3,2-g][1]benzopyran-9-yl)oxy]propoxy]-3-methyl-2-butenyl]oxy]-
| Title | Journal or Book | Year |
|---|---|---|
| Latrunculin A and Its C-17-O-Carbamates Inhibit Prostate Tumor Cell Invasion and HIF-1 Activation in Breast Tumor Cells | Journal of Natural Products | 2008 |